Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 116, Issue 8, 2009, Pages 1062-1068

  Chereau E ^a   Ballester, M ^a   Selle, F ^a   Cortez, A ^a   Pomel, C ^b,c   Darai, E ^a   Rouzier, R ^a  

^a HÔPITAL TENON   (France)

^b CENTRE JEAN PERRIN   (France)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Diaphragm surgery; Morbidity; Ovarian cancer; Pleural effusion

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CARCINOMATOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROL GROUP; CONTROLLED STUDY; CYSTIC LYMPHANGIOMA; CYTOREDUCTIVE SURGERY; DIAPHRAGM; DIAPHRAGM CARCINOMATOSIS; DIAPHRAGM DISEASE; DIAPHRAGMATIC PERITONECTOMY; DIGESTIVE FISTULA; FEMALE; FEVER; FISTULA; GYNECOLOGY; HUMAN; HUMAN TISSUE; INTESTINE RESECTION; INTRAOPERATIVE PERIOD; LUNG; LUNG EMBOLISM; LYMPHADENECTOMY; MORBIDITY; MUSCLE RESECTION; OPERATION DURATION; OUTCOME ASSESSMENT; OVARY CANCER; PARAAORTIC LYMPHADENECTOMY; PELVIS LYMPHADENECTOMY; PLEURA EFFUSION; PNEUMOTHORAX; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; THORACOCENTESIS; UNIVERSITY HOSPITAL; URINARY TRACT FISTULA;

CASE-CONTROL STUDIES; DIAPHRAGM; FEMALE; HUMANS; LUNG DISEASES; MIDDLE AGED; MUSCLE NEOPLASMS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 67651102600     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2009.02214.x     Document Type: Article

References (20)

1. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002 20 : 1248 59.
2. Chi DS, Franklin CC, Levine DA, Akselrod F, Sabbatini P, Jarnagin WR, et al. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol 2004 94 : 650 4.
3. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol 2006 100 : 283 7.
4. Cliby W, Dowdy S, Feitoza SS, Gostout BS, Podratz KC. Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol Oncol 2004 94 : 655 60.
5. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995 221 : 124 32.
6. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995 221 : 29 42.
7. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Elashoff RM. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 1983 61 : 413 20.
8. Eisenhauer EL, D'Angelica MI, Abu-Rustum NR, Sonoda Y, Jarnagin WR, Barakat RR, et al. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Gynecol Oncol 2006 103 : 871 7.
9. Committee on Practice Bulletins - Gynecology, American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 2007 110 : 429 40.
10. Aletti GD, Long HJ, Podratz KC, Cliby WA. Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer? Gynecol Oncol 2007 104 : 212 6.
11. Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Maggioni A, et al. Relationship between time interval from primary surgery to the start of taxane-plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study. J Clin Oncol 2005 23 : 751 8.
12. Rosa DD, Clamp A, Mullamitha S, Ton NC, Lau S, Byrd L, et al. The interval from surgery to chemotherapy in the treatment of advanced epithelial ovarian carcinoma. Eur J Surg Oncol 2006 32 : 588 91.
13. Paulsen T, Kaern J, Kjaerheim K, Haldorsen T, Tropé C. Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer. Gynecol Oncol 2006 102 : 447 52.
14. Brun JL, Rouzier R, Uzan S, Daraï E. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Gynecol Oncol 2008 110 : 354 9.
15. Morice P, Dubernard G, Rey A, Atallah D, Pautier P, Pomel C, et al. Results: of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer. J Am Coll Surg 2003 197 : 955 63.
16. Deppe G, Malviya VK, Boike G, Hampton A. Surgical approach to diaphragmatic metastases from ovarian cancer. Gynecol Oncol 1986 24 : 258 60.
17. Montz FJ, Schlaerth JB, Berek JS. Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer. Gynecol Oncol 1989 35 : 338 40.
18. Kapnick SJ, Griffiths CT, Finkler NJ. Occult pleural involvement in stage III ovarian carcinoma: role of diaphragm resection. Gynecol Oncol 1990 39 : 135 8.
19. Dowdy SC, Loewen RT, Aletti G, Feitoza SS, Cliby W. Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma. Gynecol Oncol 2008 109 : 303 7.
20. Devolder K, Amant F, Neven P, van Gorp T, Leunen K, Vergote I. Role of diaphragmatic surgery in 69 patients with ovarian carcinoma. Int J Gynecol Cancer 2008 18 : 363 8.